易瑞生物 (300942.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(易瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 36,475,073.45254,106,487.66165,099,285.79112,111,327.4960,707,585.25686,897,476.53572,094,603.75474,669,027.13294,001,215.63
 营业利润(元) -7,342,377.09-175,301,186.82-95,086,336.81-83,792,972.32-33,534,213.8298,107,417.54176,036,337.52184,577,369.45139,280,317.86
 利润总额(元) -7,329,724.06-177,798,044.10-96,238,802.25-83,995,058.61-33,443,386.3994,886,178.21176,076,129.02184,620,469.27139,308,119.81
 净利润(元) -7,273,762.66-184,983,355.31-99,216,611.87-69,675,890.25-28,085,394.8482,663,795.37148,291,951.07151,359,564.88114,098,297.86
 归属于母公司股东的净利润(元) -7,111,078.14-184,907,769.73-99,158,554.33-69,632,293.13-28,061,115.0382,965,490.95148,364,765.08151,413,759.86114,128,972.49
盈利能力:
 销售毛利率(%) 74.6249.9348.7339.3225.0156.5161.5764.5867.21
 销售净利率(%) -19.94-72.80-60.10-62.15-46.2612.0325.9231.8938.81
 净资产收益率(%) -0.80-20.39-10.00-7.25-2.79----
 总资产报酬率ROA(%) -0.39-13.69-7.51-7.51-2.68----
 投入资本回报率ROIC(%) -0.58-16.40-8.36-6.74-2.728.2814.3215.0111.16
营运能力:
 存货周转率(次) 0.161.930.650.470.45----
 应收账款周转率(次) 0.633.182.021.210.47----
 总资产周转率(次) 0.030.190.120.090.05----
偿债能力:
 资产负债率(%) 39.5937.4335.7224.1821.7924.7817.9319.6819.79
 股东权益比率(%) 60.3062.5964.3075.8378.2275.2482.0880.3380.08
 已获利息倍数(倍) -2.2664.6315.8811.1450.80-10.17-12.29-20.871,278.62
 流动比率 5.735.396.203.733.873.385.774.794.88
 速动比率 5.375.105.523.063.112.733.873.383.74
发展能力:
 营业收入增长率(%) -39.92-63.01-71.14-76.38-79.3514.9532.7143.63100.11
 营业利润增长率(%) 78.10-278.68-154.02-145.40-124.08-63.43-21.420.9845.83
 税后利润增长率(%) 74.66-322.87-166.83-145.99-124.59-64.92-24.17-7.2830.27
 净资产增长率(%) -10.53-12.01-8.31-12.30-12.242.1314.7917.7232.14
 总资产增长率(%) 16.065.7617.05-7.10-10.1511.2713.8517.0434.04

前瞻产业研究院